butabarbital will decrease the level or influence of doravirine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
butabarbital will decrease the extent or result of cyclosporine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
butabarbital will decrease the level or influence of ramelteon by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Mysterious.
butabarbital will decrease the level or impact of flurbiprofen by influencing hepatic enzyme CYP2C9/ten metabolism. Slight/Importance Not known.
butabarbital will minimize the level or impact of mestranol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
Felbamate: Might raise the serum focus of Barbiturates. Barbiturates may well lower the serum concentration of Felbamate. Administration: Keep an eye on for elevated barbiturate concentrations/toxicity if felbamate is initiated/dose greater, or lessened concentrations/consequences if felbamate is discontinued/dose decreased. Confer with phenobarbital dosing rules for people acquiring that agent. Observe therapy
butabarbital will reduce the level or outcome of parecoxib by influencing hepatic enzyme CYP2C9/10 metabolism. Use Caution/Keep an eye on.
fentanyl transmucosal and butabarbital each boost sedation. Keep away from or Use Alternate Drug. Restrict use to patients for whom substitute remedy choices are insufficient
butabarbital increases outcomes of ifosfamide by affecting hepatic enzyme CYP2B6 metabolism. Use Warning/Monitor. Coadministration of ifosfamide with CYP2B6 inducers may well improve metabolism of ifosfamide to its metabolite. Watch for enhanced effects/toxicities if combined with CYP2B6 inducers.
butabarbital will decrease the level or result of buprenorphine subdermal implant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Keep an eye on people currently on buprenorphine subdermal implant who call for recently-initiated procedure with CYP3A4 inducer for signs and signs of withdrawal.
butabarbital will decrease the extent or impact of paclitaxel protein sure by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unidentified.
While butabarbital is taken at bedtime, it may bring about many people to feel drowsy or considerably less notify on arising. Tend not to travel or do anything else that could be unsafe till website you know how this medication has an effect on you.
butabarbital will lessen the level or influence of tolterodine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
butabarbital will lower the extent or result of alfentanil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Not known.